Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
Saved in:
| Title: | Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition. |
|---|---|
| Authors: | Krassikova LS; Pushchino State Institute of Natural Sciences, Pushchino, Russia. l.krassikova@gmail.com.; Engelhardt Institute of Molecular Biology RAS, Moscow, Russia. l.krassikova@gmail.com., Karshieva SS; Engelhardt Institute of Molecular Biology RAS, Moscow, Russia.; N. N. Blokhin Cancer Research Center, Russia., Cheglakov IB; Engelhardt Institute of Molecular Biology RAS, Moscow, Russia.; N. N. Blokhin Cancer Research Center, Russia., Belyavsky AV; Engelhardt Institute of Molecular Biology RAS, Moscow, Russia. |
| Source: | The journal of gene medicine [J Gene Med] 2016 Sep; Vol. 18 (9), pp. 220-33. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Country of Publication: England NLM ID: 9815764 Publication Model: Print Cited Medium: Internet ISSN: 1521-2254 (Electronic) Linking ISSN: 1099498X NLM ISO Abbreviation: J Gene Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
